Related Experiment Video
Updated: Jun 24, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Molecular and gene expression analyses of chicken oncomodulin and their association with breast myopathies in
Byungwhi Kong1, Majid Shakeri1, Janghan Choi1
1USDA, Agricultural Research Service, U.S. National Poultry Research Center, Quality & Safety Assessment Research Unit, Athens, GA, USA.
Abstract:
Oncomodulins (OCMs), also known as non-α-parvalbumins, are small molecules known for their high-affinity binding of Ca2+ ions. They play crucial roles as Ca2+ buffers and participate in signaling pathways within muscle and neuron cells. In chickens, 3 oncomodulin molecules have been identified at the protein level and are named chicken oncomodulin 1 (OCM1), -3 (OCM3), and alpha-parvalbumin (PVALB). OCM4 was newly assigned by genome annotation. A gene cluster containing OCM1, OCM3, and OCM4 is located in chromosome 14, while a single gene of PVALB is on chromosome 1. The Ca2+ signaling pathway may be a potential contributor to the onset of chicken breast myopathies. However, chicken OCMs have not been extensively studied in muscle tissues. In this study, the genetic specifications, tissue-specific and differential expression of OCM1, OCM3, OCM4, and PVALB in the context of chicken breast myopathies were investigated. OCM1 exhibited moderate expression in the liver, intestine, and kidney. OCM3 was highly expressed in thymus and breast muscle. A long noncoding RNA (lncRNA) transcribed from the antisense strand of the OCM3 gene was found to be expressed in liver, lung, heart, intestine, and kidney tissues. OCM4 was barely expressed in thymus, thigh-, and breast muscle. PVALB exhibited high expression across all tissues examined. Results of quantitative PCR (qPCR) indicated that the expression of OCM3 was significantly increased (4.4 ± 0.7 fold; P-value = 0.03) in woody breast (WB) muscle and even greater (8.5 ± 0.6 fold; P-value = 0.004) in WB/white striping (WS) muscles. The expression of PVALB showed no difference in WB muscle, but it was notably higher (4.6 ± 0.7 fold; P-value = 0.054) in WB/WS muscle, although statistical significance was not reached. These findings suggest that increased expression of OCM3 and PVALB may be linked to chicken breast myopathies with regard to disruption of Ca2+ buffering.
Insights
Increased expression of oncomodulin 3 (OCM3) and alpha-parvalbumin (PVALB) in chicken breast muscle is linked to myopathies. This suggests calcium (Ca2+) buffering disruptions may contribute to these conditions.
Area of Science:
- Animal Science
- Molecular Biology
- Biochemistry
Background:
- Oncomodulins (OCMs) are Ca2+-binding proteins crucial for muscle and neuron signaling.
- Chicken OCMs (OCM1, OCM3, OCM4) and alpha-parvalbumin (PVALB) are involved in Ca2+ buffering.
- Chicken breast myopathies may involve Ca2+ signaling pathway disruptions.
Purpose of the Study:
- Investigate the genetic specifications and tissue-specific expression of OCM1, OCM3, OCM4, and PVALB.
- Determine the role of these proteins in chicken breast myopathies.
- Explore potential links between OCM/PVALB expression and Ca2+ buffering in myopathic conditions.
Main Methods:
- Gene annotation and identification of OCM and PVALB genes.
- Tissue-specific expression analysis using quantitative PCR (qPCR).
- Differential expression analysis in normal versus myopathic chicken breast muscle (Woody Breast, White Striping).
Main Results:
- OCM3 showed high expression in thymus and breast muscle, with significantly increased levels in Woody Breast (WB) and WB/White Striping (WS) muscles.
- PVALB was highly expressed across all tissues, with a notable increase in WB/WS muscle.
- A long noncoding RNA (lncRNA) associated with OCM3 was detected in various non-muscle tissues.
Conclusions:
- Elevated OCM3 expression is strongly associated with chicken breast myopathies.
- Increased PVALB expression may also contribute to WB/WS myopathies.
- Aberrant Ca2+ buffering due to altered OCM3 and PVALB levels is a potential mechanism underlying chicken breast myopathies.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019